Apple AirPods Pro 3 vs Otofonix Encore

The Apple AirPods Pro 3 is a budget-priced OTC hearing aid released in 2025, earning a B grade with a SoundScore of 3.3/5 in our lab testing. At $250, it sits in the most affordable price tier of OTC devices, though its overall sound performance ranks #49 of 65 in the category. This device delivers standout performance in music streaming, scoring a strong 4.3/5—a full 2.38 points above the category average. Feedback handling is equally impressive at 5.0/5, meaning users can expect excellent stability without whistling or squealing during normal use. These strengths make the AirPods Pro 3 particularly appealing for users who prioritize media consumption alongside hearing assistance. However, speech clarity presents a more mixed picture. Speech in quiet scores 2.3/5, falling 0.53 points below the category average. Speech in noise measures 1.8/5, which is above the category average but still low in absolute terms. Own-voice comfort also trails at 1.9/5, sitting 0.61 points below typical OTC performance. The AirPods Pro 3 is best suited for users already invested in the Apple ecosystem who want hearing assistance combined with premium streaming quality. Those prioritizing speech understanding in conversations may want to explore alternatives like the Apple AirPods Pro 2, which scores higher overall at a lower listed price, or the Elehear Beyond at the top of this price range.

The Otofonix Encore is a behind-the-ear prescription hearing aid priced at $295, placing it in the budget tier of the prescription category. In our lab testing, it earned a C grade with a SoundScore of 2.7/5, ranking 35th out of 36 prescription hearing aids tested. Sound performance presents significant challenges across most metrics. Speech clarity scores are low in both quiet (1.0/5) and noisy environments (1.0/5), falling 2.32 and 0.96 points below category averages respectively. Music streaming capability is essentially absent at 0.0/5, and own-voice comfort is notably limited at 0.1/5 in the tuned configuration—2.65 points below the category average. The one bright spot is feedback handling, which scores an excellent 4.7/5. While this falls just 0.01 points below the category average, it represents strong absolute performance that should minimize whistling issues during daily use. This device runs on disposable batteries. At this price point, shoppers should be aware that the RxEars Rxi offers substantially better sound performance (4.09/5) in the same price range. The Otofonix Encore may suit budget-conscious consumers who prioritize feedback stability over speech clarity and streaming features, but our testing suggests most users would benefit from considering higher-performing alternatives within this price tier.